[13] The 1,200mg Daily Threshold Research identifies 1,200mg daily calcium as the optimal intake threshold for maximal bone protection
Additionally, the GLP-1R/glucagon receptor (GCGR) dual agonist, managed by Innovent Biologics and Eli Lilly, has reached Phase III clinical trials in China with type 2 diabetes patients, demonstrating significant reductions in blood sugar, weight loss, and cardiovascular and kidney benefits
Additionally, these agents help regulate postprandial glucose by suppressing hepatic glucose production and delaying gastric emptying
Most glutathione supplements available are capsules and liposomal liquids
The FDA has addressed tirzepatide shortage status multiple times, and the legal landscape continues to shift
GLP-1 drugs were a breakthrough, but not the final answer